Antibiotic resistance of urinary tract pathogens and rationale for empirical intravenous therapy

Pediatric Nephrology

Volumn 19, Issue 9, 2004, Pages 982-986

  Haller, Maria ^a   Brandis, Matthias ^a   Berner, Reinhard ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Antibiotic susceptibility pattern; Enterobacteriaceae; Enterococcus; Escherichia coli; Rational antibiotic therapy; Urinary tract infection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEFOTAXIME; CEFOTIAM; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; NETILMICIN; NITROFURANTOIN; PIPERACILLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CITROBACTER; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEUS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; URINALYSIS; URINARY TRACT INFECTION;

BACTERIA; CHILD; DRUG RESISTANCE, BACTERIAL; HUMANS; INJECTIONS, INTRAVENOUS; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 4544247469     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1528-7     Document Type: Article

References (24)

1. Siegel SR, Siegel B, Sokoloff BZ, Kanter MH (1980) Urinary infection in infants and preschool children: five-year follow-up. Am J Dis Child 314:369-372
2. Jodal U (1987) The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1:713-729
3. Jakobsson B, Berg U, Svensson L (1994) Renal scarring after acute pyelonephritis. Arch Dis Child 70: 111-115
4. Jantunen ME, Siitonen A, Ala-Houhala M, Ashorn P, Föhr A, Koskomies O, Wikström S, Syen H (2001) Predictive factors associated with significant urinary tract abnormalities in infants with pyelonephritis. Pediatr Infect Dis J 20:597-601
5. Berner R, Schumacher RF, Bartelt S, Forster J, Brandis M (1998) Bacteremia in hospitalized children: predisposing conditions and case-related microorganisms. Eur J Clin Microbiol Infect Dis 17:337-340
6. Mathai D, Jones RN, Pfaller MA, SENTRY Participant Group North America (2001) Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,5 10 hospitalized patients: a report from the SENTRY antimicrobial surveillance program (North America). Diagn Microbiol Infect Dis 40:129-136
7. Goldraich NP, Manfroi A (2002) Febrile urinary tract infection: Escherichia coli susceptibility to oral antimicrobials. Pediatr Nephrol 17:173-176
8. Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444-445
9. Prais D, Straussberg R, Avitzur Y, Nussinovitch M, Harel L, Amir J (2003) Bacterial susceptibility to oral antibiotic in community acquired urinary tract infection. Arch Dis Child 88:215-218
10. National Committee for Clinical Laboratory Standards (2002) Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. Approved standard, document M100-S12. NCCLS, Wayne, Pa., 19087-1898
11. Chow JW (2000) Aminoglycoside resistance in enterococci. Clin Infect Dis 31:586-589
12. Bronzwaer SLAM, Cars O, Buchholz U, Möästad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJW, Degener JE, and participants in the European Antimicrobial Surveillance System (2002) A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 8:278-282
13. Patterson JE (2002) Extended spectrum beta-lactamases: a therapeutic dilemma. Pediatr Infect Dis J 21:957-959
14. Bonnet R (2004) Growing group of extended-spectrum betalactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48:1-14
15. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgensen JH (2000) Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 21:455-458
16. Toltzis P, Dul M, O'Riordan MA, Salvator A, Rosolowski B, Toltzis H, Blumer JL (2003) Cefepime use in pediatric intensive care unit reduces colonization with resistant bacilli. Pediatr Infect Dis J 22:109-114
17. Swartz MN (1997) Use of antimicrobial agents and drug resistance. N Engl J Med 337:491-492
18. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ, for the Workshop to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals (1996) Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. JAMA 275:234-240
19. Carapetis JR, Jaquiery AL, Buttery JP, Starr M, Cranswick NE, Kohn S, Hogg GG, Woods S, Grimwood K (2001) Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J 20:240-246
20. Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444-445
21. Ferry S, Burman LG, Holm SE (1988) Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing. Scand J Infect Dis 20:535-544
22. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M, Hearney DH, Reynolds EA, Ruley J, Janosky JE (1999) Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 104:79-86
23. Benandor D, Neuhaus TJ, Papayzan JP, Will UV, Engel-Bicik I, Nadal D, Slosman D, Mermillod B, Girardin E (2001) Randomised controlled trial of three days versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 84:241-246
24. Michael M, Hodson EM, Craig JC, Martin S, Mayer VA (2002) Short compared with standard duration of antibiotic treatment for urinary tract infections: a systematic review of randomised controlled trials. Arch Dis Child 87:118-123